Cardiovascular Pharmacotherapeutics Update: Stroke Prevention in Atrial Fibrillation
This session will look at stroke prevention in patients with atrial fibrillation. Discussion of the key differences in the pharmacologic profiles of various oral chronic anticoagulation agents that influence treatment selection for individual patients with atrial fibrillation who are at risk of stroke.
Credits: 1.50 contact hours; 1.50 are pharmacology
Release Date: March 1, 2021
End Date: March 1, 2022
As a result of this learning activity, you will be able to:
- Review evidence-based scoring assessment to risk stratify adults with AFib while considering stroke and bleeding risks
- Compare and contrast pharmacologic profiles of the options for chronic oral anticoagulants that influence the selection of a specific agent for an individual patient with chronic atrial fibrillation
- Discuss starting and target dosing options for oral anticoagulant therapy for adults with atrial fibrillation, including those with kidney or liver impairment and other patient-related factors
- Review drug-drug interactions related to various chronic anticoagulation treatment options
- Discuss patient teaching related to the use of various chronic anticoagulation including monitoring drug levels as appropriate and possible drug-food interactions
Leslie L. Davis, PhD, RN, ANP-BC, FAANP, FACC, FAHA, FPCNA
Associate Professor of Nursing at the University of North Carolina at Chapel Hill, School of Nursing, PhD Division
Dr. Leslie Davis is a full-time faculty member of the School of Nursing at the University of North Carolina at Chapel Hill. She maintains a part time nurse practitioner(NP) practice with the Division of Cardiology at the University of North Carolina at Chapel Hill. Dr. Davis is a fellow in the American Association of Nurse Practitioners, the American Collège of Cardiology, the American Heart Association, and the Preventive Cardiovascular Nurses Association. She is also a certified hypertension clinician through the American Society of Hypertension. As a clinician, she focuses her care on adults with hypertension, heart failure, and acute coronary syndromes. Her research interests include self-care and symptom management with women who have experienced cardiovascular conditions. She has served as editor for the book Cardiovascular Nursing Secrets (2004), as guest editor for two special cardiovascular editions in the Journal for Nurse Practitioners (2013 and 2019), has authored/coauthored articles 35+ papers in peer-reviewed journals, 13 book chapters, and other scholarly products related to cardiovascular topics.
As a nurse practitioner, Dr. Davis sees patients with difficult to control high blood pressure in the UNC Hypertension Clinic, where a multidisciplinary approach utilizes both lifestyle modification and medications, as well as investigative techniques, to treat hypertension. She also sees patients in the general cardiology clinic and the UNC Heart and Vascular Center.
Obtain Your Credits
To earn credits for this activity, you must complete all course components in the following order: 1) complete a three-question pre-test; 2) watch the course presentation video; 3) complete the course evaluation; 4) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile dashboard transcript for future access.
NPACE designates this educational activity for a maximum of 1.50 contact hours, of which 1.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
Contributing faculty, Leslie L. Davis, PhD, RN, ANP-BC, FAANP, FACC, FAHA, FPCNA, have disclosed no relevant financial relationships.
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
There is no commercial support for this activity.
|Access Date||Quiz Result||Score||Actions|